Graeser et al. showed that sporadic breast cancers with lower Rad51 scores (Rad51 foci formation following anthracycline-based chemotherapy) showed decreased HR and increased sensitivity to anthracycline-based chemotherapy [42]. Here, RAD51 is linked to breast carcinoma.